Aromatic Polyketides From a Marine-Derived Streptomyces Species

Area of Science:

• Marine Natural Products Chemistry
• Neuroscience
• Medicinal Chemistry

Background:

• Marine-derived microorganisms, such as Streptomyces species, are prolific sources of structurally diverse secondary metabolites.
• Amyloid-β 42 (Aβ42) peptide aggregation is a central pathological hallmark of Alzheimer's disease.
• Identifying novel inhibitors of Aβ42 aggregation is crucial for developing therapeutic strategies against Alzheimer's disease.

Purpose of the Study:

• To isolate and characterize new chemical entities from the marine-derived Streptomyces sp. OUCMDZ-4182.
• To evaluate the inhibitory potential of isolated compounds against amyloid-β 42 (Aβ42) aggregation.

Main Methods:

• Isolation and purification of compounds using chromatographic techniques.
• Structure elucidation employing comprehensive spectroscopic analyses (NMR, MS) and quantum chemical calculations.
• In vitro assessment of Aβ42 aggregation inhibition using biochemical assays.

Main Results:

• Three new naphthalene derivatives, designated strepthalenes A-C (1-3), were isolated, along with the known analogue (S)-DNPA (4) and six anthraquinones (5-10).
• Strepthalenes B and C demonstrated moderate inhibitory activity against Aβ42 aggregation, with IC50 values of 47.65 µM and 24.73 µM, respectively.
• The structures of the new compounds were confirmed through detailed spectroscopic data and computational methods.

Conclusions:

• The marine actinomycete Streptomyces sp. OUCMDZ-4182 produces novel naphthalene derivatives with potential anti-amyloidogenic properties.
• Strepthalenes B and C represent promising lead compounds for further investigation in the context of Alzheimer's disease therapeutics.
• This study expands the known chemical diversity of marine-derived Streptomyces and highlights their potential in drug discovery.